You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ILUVIEN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ILUVIEN

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00770770 ↗	Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina	Terminated	Alimera Sciences	Phase 2	2009-05-01	This study will assess the safety and efficacy of FA Intravitreal Inserts in subjects with macular edema secondary to RVO.
NCT01304706 ↗	Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study	Completed	Alimera Sciences	Phase 3	2011-04-01	This study will assess the safety and utility of the new inserter for the administration of ILUVIEN in subjects with diabetic macular edema.
NCT02359526 ↗	A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients	Completed	Association for Innovation and Biomedical Research on Light and Image	Phase 4	2014-10-01	To provide treating physicians with experience with ILUVIEN as well as monitoring its safety (and effectiveness) in a real-life chronic diabetic macular edema (DME) patients judged insufficiently responsive to available therapies.
NCT02424019 ↗	Phase 4 IOP Signals Associated With ILUVIEN®	Unknown status	Alimera Sciences	Phase 4	2015-05-06	This study will assess the safety in patients treated with ILUVIEN, with primary focus on IOP.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ILUVIEN

Condition Name

Chart
Table

Condition Name for ILUVIEN
Intervention	Trials
Diabetic Macular Edema	5
Chronic Diabetic Macular Edema	1
Diabetes	1
Diabetic Macular Edema (DME)	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ILUVIEN
Intervention	Trials
Macular Edema	8
Edema	7
Retinal Vein Occlusion	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ILUVIEN

Trials by Country

Map
Table

Trials by Country for ILUVIEN
Location	Trials
United States	44
Puerto Rico	1
Portugal	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ILUVIEN
Location	Trials
Georgia	3
California	2
Arizona	2
Ohio	2
Massachusetts	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ILUVIEN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ILUVIEN
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	1
Phase 2/Phase 3	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ILUVIEN
Clinical Trial Phase	Trials
Completed	3
Withdrawn	2
Unknown status	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ILUVIEN

Sponsor Name

Chart
Table

Sponsor Name for ILUVIEN
Sponsor	Trials
Alimera Sciences	5
Association for Innovation and Biomedical Research on Light and Image	1
Johns Hopkins University	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ILUVIEN
Sponsor	Trials
Industry	5
Other	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.